Inspire Medical Systems (INSP) Shows Improved Sleep Apnea Outcomes with Inspire V System

Inspire Medical Systems, Inc. (NYSE:INSP) ranks among the best medical device stocks to invest in. On October 10, Inspire Medical Systems, Inc. (NYSE:INSP) published clinical data demonstrating the effectiveness of its Inspire V system in treating patients with obstructive sleep apnea. The data includes a restricted U.S. market release at ten medical centers and the findings of a clinical investigation conducted in Singapore.

Comparing the Singapore experiment to the prior Inspire IV system showed a 20% decrease in surgical times for 44 patients. The company reports that all procedures were successfully completed. The study also demonstrated that the Inspire V system outperformed its predecessor in respiratory sensing, with an inspiratory phase overlap percentage of 87.1% against 79.4%.

Inspire Medical Systems, Inc. (NYSE:INSP) is a medical technology company that develops and commercializes innovative, minimally invasive solutions for obstructive sleep apnea (OSA).

While we acknowledge the potential of INSP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.